Skip to content

Postprandial Glucose Excursions with Difficult Foods in Children with Type 1 Diabetes on Hybrid Closed Loop Therapy: A Pilot Study.

Postprandial Glucose Excursions with Difficult Foods in Children with Type 1 Diabetes on Hybrid Closed Loop Therapy: A Pilot Study.

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000061831
Enrollment
10
Registered
2021-01-25
Start date
2020-06-02
Completion date
2020-10-07
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Families of children with type 1 diabetes (T1D) have reported high fat and high protein (HF/HP) meals as ‘difficult’ foods, causing prolonged hyperglycaemia after eating. A newly developed Hybrid Closed Loop (HCL) system with an Auto-Mode function uses real-time glucose levels to deliver basal insulin in micro amounts. Yet, there is little evidence on whether Auto-Mode is more effective than standard insulin pump therapy (Manual Mode) at reducing glucose excursions caused by HF/HP foods. This pilot study examines the impact of Auto-Mode on glucose excursions following HF/HP meals compared to Manual Mode. Participants are asked to consume standardised frozen beef lasagne and margherita pizza two nights a week for four weeks, under controlled conditions (4 meals in Manual Mode, 4 meals in Auto-Mode). It is hypothesised that the use of the Auto Mode will reduce glucose excursions after eating HF/HP foods when compared to the participant’s preferred insulin bolus pattern delivery in Manual Mode.

Interventions

This study is a quantitative prospective cross-over design study under free-living conditions. Participants will be using their personal Medtronic MiniMed 670G insulin pump and their Guardian G3 continuous glucose monitoring (CGM) sensor. Each participant will be re-educated by an accredited practising dietitian on how to bolus for high fat and high protein meals using standard insulin pump therapy (Manual Mode). This will be a 20 minute phone call with each participant. After this, they will

This study is a quantitative prospective cross-over design study under free-living conditions. Participants will be using their personal Medtronic MiniMed 670G insulin pump and their Guardian G3 continuous glucose monitoring (CGM) sensor. Each participant will be re-educated by an accredited practising dietitian on how to bolus for high fat and high protein meals using standard insulin pump therapy (Manual Mode). This will be a 20 minute phone call with each participant. After this, they will have a 2 week run-in period to help optimise their pump settings before commencing the study. Study participants are randomised to begin the study in either Manual Mode or Auto Mode (Hybrid Closed Loop therapy). Participants will be asked to consume 2 standardised frozen beef lasagne meals and 2 standardised frozen margarita pizza meals in each Mode at dinner time (4 dinner study meals in Manual Mode, 4 dinner study meals in Auto Mode). This is a total of 2 nights a week for 4 weeks. There will be no wash out period between the meals as we will not be comparing the effects of a control drug to an intervention drug. Postprandial glucose excursions after eating each study meal in Auto and Manual Mode will be compared. Regular phone calls and text messages will be made to each family after each meal to monitor adherence to the intervention.

Sponsors

Telethon Kids Institute
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

• Type 1 diabetes for more than 1 year • Aged 8 to 18 years • HbA1c less than or equal to 8.5% • On hybrid closed loop therapy for more 1 month and using Auto Mode • Willing and able to consume the test meals containing meat and gluten (pizza and pasta) • Non Halal and non Kosher • Access to internet

Exclusion criteria

• Patients with dietary restrictions (e.g. coeliac disease) – test meals contain gluten • Patients with clinical gastroparesis

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026